Cervical Spondylosis

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Providence Therapeutics
1 program
DTRAX GraftN/A1 trial
Active Trials
NCT01616719WithdrawnEst. Feb 2015
Globus Medical
Globus MedicalAUDUBON, PA
1 program
NuVasive® ACP System StudyN/A1 trial
Active Trials
NCT05066711Enrolling By Invitation75Est. Jun 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Globus MedicalNuVasive® ACP System Study
Providence TherapeuticsDTRAX Graft

Clinical Trials (2)

Total enrollment: 75 patients across 2 trials

NCT05066711Globus MedicalNuVasive® ACP System Study

NuVasive® ACP System Study

Start: May 2022Est. completion: Jun 202775 patients
N/AEnrolling By Invitation

Evaluation of DTRAX Graft in Patients With Cervical Degenerative Disc Disease

Start: May 2012Est. completion: Feb 2015
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space